The unexpected backtrack for clinical trial transparency in Europe
Following the recent revelation that the EMA’s policy on proactive publication of clinical trial data wasn’t quite what had been expected, we look at how… Read more »
Ella Flemyng
Journal Development Manager at BioMed Central
Within BMC, Ella oversees a portfolio of open-access, applied-methodology journals within health sciences that aim to improve the design, conduct and reporting of different study designs. She is an advocate for improving research integrity and seeing publishing and peer review develop to meet the needs of the research community. Before working in publishing, Ella completed a Master's of Science in biomedical and molecular science at Kings College London.
Latest posts by Ella Flemyng (see all)
- Patient peer review in academic journals: Next steps in the journey - 10th September 2018
- Increasing diversity in peer review with transparent mentoring of early career researchers - 11th June 2018
- Completed our Clinical Trials Day Quiz? Read about what’s next for clinical trial reporting - 19th May 2017
BioMed Central's Case Report of the Year: lessons for modern life
“It is case reports themselves that must be the first line of evidence” – Milos Jenicek Medical case histories have been documented since the time of… Read more »
Final countdown for the EU Clinical Trials Regulation
“Truth never damages a cause that is just” – Mahatma Gandhi Today, European Parliament will vote on the EU Clinical Trials Regulation, including… Read more »